Commentary: Efficacy and safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves' ophthalmopathy: a systematic review and meta-analysis

Saved in:

Bibliographic Details
Published in:	Frontiers in endocrinology (Lausanne) Vol. 15; p. 1394616
Main Authors:	Li, Lingxiao, Wu, Jihong
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 28-05-2024
Subjects:	Administration, Intravenous Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use comment efficacy Endocrinology Graves Ophthalmopathy - drug therapy Graves Ophthalmopathy - immunology Graves’ ophthalmopathy Humans meta-analysis monoclonal antibodies Severity of Illness Index Treatment Outcome Graves’ ophthalmopathy meta-analysis comment efficacy monoclonal antibodies
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Scholarly Journals-1 ObjectType-Commentary-4 ObjectType-Feature-2 ObjectType-Undefined-1 content type line 23 ObjectType-Article-3 Edited by: Ajay Pradhan, AstraZeneca, Sweden Ceyhun Bereketoglu, Marmara University, Türkiye Reviewed by: Danilo Villagelin, Pontifical Catholic University of Campinas, Brazil
ISSN:	1664-2392 1664-2392
DOI:	10.3389/fendo.2024.1394616